Teva records another victory in US Supreme Court Copaxone ruling

20-01-2015

The US Supreme Court has vacated an appeals court judgment that invalidated a patent covering Teva’s blockbuster drug Copaxone (glatiramer acetate). 


Copaxone, Teva, US Supreme Court, Sandoz, claim construction

LSIPR